See also this year's filing and all EDGAR filings for this company.
PDF Report 0001005201_2012_Assertio_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001005201, Assertio Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 109,489,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,070,000 |
| 3 | remainder_Assets | 53,813,000 |
| 4 | LiabilitiesCurrent | 39,840,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 81,544,000 |
| 9 | ResearchAndDevelopmentExpense | 15,187,000 |
| 10 | remainder_Expenses | -34,060,000 |
| 11 | remainder_Revenues | 132,973,000 |
| 12 | remainder_NetIncome | 424,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 164,372,000 |
| 1 | Liabilities | 39,840,000 |
| 2 | Expenses | 62,671,000 |
| 3 | Revenues | 132,973,000 |
| 4 | StockholdersEquity | 124,532,000 |
| 5 | NetIncome | 70,726,000 |
| 6 | ComprehensiveNetIncome | 70,726,000 |
| 7 | BaseVar | 200,140,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.35 |
| 9 | EconomicCapitalRatio | 3.93 |
Edgar->Model Mapping
Feature Distribution
